Kyle Lefkoff is the Founder and General Partner of Boulder Ventures. See sector focus and contact routes.
Kyle Lefkoff is the Founder and General Partner of Boulder Ventures, where he brings 39 years of venture capital experience and has personally invested in 65 Colorado companies[1][2]. His investment thesis focuses exclusively on early-stage information technology and biotechnology companies located in Colorado and the Mid-Atlantic regions[5][8]. While specific check sizes and lead/follow behavior are not publicly detailed for his individual activity, he is recognized as an angel investor with interests in software, networking, and data storage[4]. Notable portfolio companies include Array BioPharma, which he co-founded and chaired before its $11.8 billion acquisition by Pfizer, as well as Dharmacon, ArcherDX, and Hauser Chemical Research[1][3][6]. Lefkoff distinguishes his approach by treating venture investing and serious alpinism as parallel crafts, applying mountain guiding risk management to help founders navigate high-consequence business environments[3]. He maintains a philosophy of directing credit toward others and prioritizing durability and realized returns over quick wins or paper marks[3].
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Boulder.
Investors like Kyle Lefkoff · Full investor directory · Investor access · Company funding database